bpc 157 fibromyalgia clinical trial BPC-157 – No Proof Required! | Office for Science and Society Regeneration or Risk? A Narrative
Description
[DOI] [PubMed] [Google Scholar] 77.Hely M.A., Morris J.G., Reid W.G., Trafficante R
The lower bacterial mucinolytic activity is supposed to contribute to the slower mucus turnover and to the leaky gut, leading to intestinal inflammation
The powder inside that vial is delicate
Beusenberg M
